-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TSbYRPdi18BVsmgdZ5e9sHc2f4Pj2F8Z25XVTwFs6fYi/t+zqJD3hW3J1dummZg9 6KNPaT4R1sklfeUs80quAw== 0001264908-06-000003.txt : 20060518 0001264908-06-000003.hdr.sgml : 20060518 20060518131038 ACCESSION NUMBER: 0001264908-06-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060517 FILED AS OF DATE: 20060518 DATE AS OF CHANGE: 20060518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRANGE DAVID L CENTRAL INDEX KEY: 0001264908 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 06851358 BUSINESS ADDRESS: STREET 1: 3151 S 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 BUSINESS PHONE: 9102510081 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2006-05-17 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001264908 GRANGE DAVID L 27W 631 SWAN LAKE DRIVE WHEATON IL 60187 1 0 0 0 Common Stock 5224 D Stock Options (to buy) 35.38 2006-05-17 4 A 0 3973 0 D 2006-05-17 2016-05-16 Common Stock 3973 3973 D Stock Options (to buy) 15.06 2004-05-19 2014-05-18 Common Stock 16000 16000 D Stock Options (to buy) 23.79 2005-05-18 2015-05-17 Common Stock 5458 5458 D Lisa C. Noecker attorney-in-fact for David L. Grange 2006-05-18 -----END PRIVACY-ENHANCED MESSAGE-----